Needle EMG Guided Injection Applications
Needle EMG guided injection can be instrumental in improving efficacy of treatment, reducing side effects and iatrogenic results, in a number of very important clinical areas. Myoguide needle EMG guided injection system is the tool to improve your clinical results.
If you would like to request information or a quotation for one of our products or have any questions, email us at info@intronixtech.com
Movement Disorders
The therapeutic use of botulinum neurotoxins (BTX) has evolved most dramatically in the field of movement disorders and has been applied to a wide spectrum of dyskinesias. In addition to the clinical benefits derived from BTX therapy in a variety of movement disorders, studies of the neurophysiologic effects of BTX have provided considerable insights into the functional organization and control of neuromuscular activity.
Non-inflammatory Pain
A majority of these neurological disorders can be identified with “trigger points” in a muscle group. The treatment of choice is the introduction of chemicals that de-enervate these trigger points – accordingly, sales of neurotoxins such as Botulinum Toxin, are escalating rapidly. There are also alternative medicine alternatives, such as "biopuncture", that can be carried out in a cost effective manner.
Irritable Bladder Syndrome
Irritable bladder syndrome is marked by increased and frequent urine release, reduced bladder capacity and loss of bladder control. Injection of Botox® into the urinary sphincter muscle can increase bladder capacity and reduce frequency of urination. The overall incidence of bladder detrusor instability in the general population is estimated at 10%. (BJOG: An International Journal of Obstetrics and Gynecology 104 (12), 1409–1412.) EMG guided injection is an important tool in the management of irritable bladder syndrome.
Botox® Cosmetic
Cosmetic treatments with Botox® have been growing at an exponential rate for many years.
The role of EMG guidance in this field is focused on specific areas where injection accuracy is depended on to avoid vital structures.
Poor injection targeting can result in a droopy appearance for
3-4 months. This is a dreaded iatrogenic result that can be avoided by simply
using EMG guidance to confirm injection into the muscle of interest.
This is particularly useful for new injectors looking for confirmation
before injecting drugs into patients. The need to increase accuracy when injecting
neuromodulators has been highlighted by recent FDA
reviews of the dangers of peripheral effects.